Interim- and posttreatment response to neoadjuvant chemotherapy assessed by 18F-FDG PET/CT for the prediction of outcome in osteosarcoma of the extremities

Conclusions: The %changes of SUVmax both on PET2 and PET3 could predict the outcome of patients with osteosarcoma of the extremities. The %changes of SUVmax on PET3 better predicted the outcome than histologic response.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Kong, C.-B., Byun, B. H. Tags: Sarcoma/ Melanoma Source Type: research